PharVision Advisers »

Anika Therapeutics shares owned by PharVision Advisers

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $389k 41k 9.40

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Anika Therapeutics

BlackRock
Trigran Investments
Caligan Partners
Vanguard Group
Acadian Asset Management
Dimensional Fund Advisors
Capital Management Corporation
Boothbay Fund Management
Renaissance Technologies
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Envestnet Asset Management
Northern Trust
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics